Literature DB >> 9500557

Insulin stimulates epinephrine release under euglycemic conditions in humans.

C J Tack1, J W Lenders, J J Willemsen, J A van Druten, T Thien, J A Lutterman, P Smits.   

Abstract

In healthy subjects, acute physiological hyperinsulinemia induces activation of the sympathetic nervous system, but in the absence of hypoglycemia, plasma epinephrine levels have not been found to increase during insulin administration. However, the venous level of epinephrine reflects the net result of release, clearance, and uptake and therefore is not a good measure of adrenomedullary epinephrine secretion. The influence of 90 minutes of euglycemic physiological hyperinsulinemia (60 mU x m(-2) x min(-1); plasma insulin concentration, approximately 700 pmol x L[-1]) on epinephrine kinetics using the 3H-epinephrine tracer method was studied in 12 healthy normotensive, non-obese subjects. After bolus injection, [3H]-epinephrine was continuously infused with arterial and venous blood sampling at regular intervals, enabling calculation of total body (systemic) and forearm epinephrine release and clearance. Studies were performed in the basal state and during sympathetic stimulation by lower-body negative pressure (LBNP) of -15 mm Hg for 15 minutes. Control experiments ("sham" clamps, but with LBNP) were performed in four of the 12 individuals. Euglycemic hyperinsulinemia (all arterial glucose samples > or = 4.2 mmol x L[-1]) induced an increase of the arterial epinephrine concentration (P = .03), and tended to increase total body epinephrine release (P = .08). Total body epinephrine clearance did not change during hyperinsulinemia. The insulin-induced increase in forearm blood flow ([FBF] by plethysmography, from 3.0 +/- 0.4 to 3.8 +/- 0.6 mL x dL(-1) x min(-1), P = .01) was strongly correlated with the increase in arterial epinephrine (r = .78, P < .01). Plasma epinephrine concentrations did not change during control experiments (sham clamp). Sympathetic stimulation alone as induced by LBNP did not stimulate epinephrine release. However, the combination of insulin and LBNP significantly increased epinephrine release (from 0.37 +/- 0.06 to 0.56 +/- 0.12 nmol x m(-2) x min(-1), P = .03). We conclude that acute physiological hyperinsulinemia under euglycemic conditions induces epinephrine release. This effect is enhanced when hyperinsulinemia is combined with sympathetic stimulation by LBNP. Due to increased forearm removal, venous epinephrine concentrations hardly change. Epinephrine release was strongly correlated with the hemodynamic effects of insulin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500557     DOI: 10.1016/s0026-0495(98)90251-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  Seven days of aerobic exercise training improves conduit artery blood flow following glucose ingestion in patients with type 2 diabetes.

Authors:  Catherine R Mikus; Seth T Fairfax; Jessica L Libla; Leryn J Boyle; Lauro C Vianna; Douglas J Oberlin; Grace M Uptergrove; Shekhar H Deo; Areum Kim; Jill A Kanaley; Paul J Fadel; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

2.  Correlates of venous catecholamine concentrations in patients with type 1 diabetes during a cold pressor test.

Authors:  D Luft; C Maisch; V Hofmann-Krück; M Radjaipour; H U Häring
Journal:  Clin Auton Res       Date:  2000-06       Impact factor: 4.435

3.  Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance.

Authors:  D Quilliot; L Fluckiger; F Zannad; P Drouin; O Ziegler
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

4.  Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter.

Authors:  P Valensi; S Chiheb; M Fysekidis
Journal:  Diabetologia       Date:  2013-04-13       Impact factor: 10.122

5.  Euglycemic hyperinsulinemia differentially modulates circulating total and acylated-ghrelin in humans.

Authors:  M O Weickert; C V Loeffelholz; A M Arafat; C Schöfl; B Otto; J Spranger; M Möhlig; A F Pfeiffer
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

6.  Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy.

Authors:  Kathryn M Canniff; Marta S Smith; D Brooks Lacy; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03-23       Impact factor: 3.619

7.  Neuropeptide Y level in paraventricular nucleus of experimental diabetic rats: correlation with sympathetic activity and body weight.

Authors:  Pallab K Ganguly
Journal:  Int J Gen Med       Date:  2010-10-05

8.  Glucagon-like peptide-1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men.

Authors:  Ali Asmar; Meena Asmar; Lene Simonsen; Sten Madsbad; Jens J Holst; Bolette Hartmann; Charlotte M Sorensen; Jens Bülow
Journal:  Physiol Rep       Date:  2017-02

9.  Euglycemic hyperinsulinemia alters the response to orthostatic stress in older adults with type 2 diabetes.

Authors:  Kenneth M Madden; Gale Tedder; Chris Lockhart; Graydon S Meneilly
Journal:  Diabetes Care       Date:  2008-08-20       Impact factor: 17.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.